• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Outcomes of Cancer Patients Undergoing Transcatheter Aortic Valve Replacement.

作者信息

Jain Vardhmaan, Saad Anas M, Gad Mohamed M, Bansal Agam, Abdelfattah Omar, Farwati Medhat, Ahuja Keerat Rai, Yun James, Krishnaswamy Amar, Kapadia Samir R

出版信息

JACC CardioOncol. 2020 Sep 15;2(3):506-508. doi: 10.1016/j.jaccao.2020.05.023. eCollection 2020 Sep.

DOI:10.1016/j.jaccao.2020.05.023
PMID:34396258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8352026/
Abstract
摘要

相似文献

1
Outcomes of Cancer Patients Undergoing Transcatheter Aortic Valve Replacement.接受经导管主动脉瓣置换术的癌症患者的结局
JACC CardioOncol. 2020 Sep 15;2(3):506-508. doi: 10.1016/j.jaccao.2020.05.023. eCollection 2020 Sep.
2
Incidence, Temporal Trends, and Associated Outcomes of Vascular and Bleeding Complications in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry.经股动脉主动脉瓣置换术患者血管和出血并发症的发生率、时间趋势及相关结局：来自胸外科医师学会/美国心脏病学会经导管瓣膜治疗登记处的分析。
Circ Cardiovasc Interv. 2020 Jan;13(1):e008227. doi: 10.1161/CIRCINTERVENTIONS.119.008227. Epub 2020 Jan 15.
3
Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.经股动脉途径行植入前瓣膜成形术与经心尖途径行导管主动脉瓣置换术时省略瓣膜成形术患者的装置成功率及30天临床结局
J Thorac Cardiovasc Surg. 2015 Nov;150(5):1111-7. doi: 10.1016/j.jtcvs.2015.07.050. Epub 2015 Jul 26.
4
Impact of Coronary Artery Revascularization Completeness on Outcomes of Patients With Coronary Artery Disease Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis of Studies Using the Residual SYNTAX Score (Synergy Between PCI With Taxus and Cardiac Surgery).经皮冠状动脉介入治疗与外科手术联合应用紫杉醇洗脱支架与心脏手术治疗（SYNTAX 评分研究中的协同作用）评估经导管主动脉瓣置换术后冠状动脉疾病患者冠状动脉血运重建完全程度对其结局的影响：荟萃分析应用残余 SYNTAX 评分
Circ Cardiovasc Interv. 2018 Mar;11(3):e006000. doi: 10.1161/CIRCINTERVENTIONS.117.006000.
5
Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).慢性肺部疾病合并重度主动脉瓣狭窄患者行经导管主动脉瓣置换术与外科主动脉瓣置换术或标准治疗的结局：PARTNER 试验（经导管主动脉瓣植入术）的观察结果。
J Am Coll Cardiol. 2014 Jan 28;63(3):269-79. doi: 10.1016/j.jacc.2013.09.024. Epub 2013 Oct 16.
6
Serum albumin in patients undergoing transcatheter aortic valve replacement: A meta-analysis.经导管主动脉瓣置换术患者的血清白蛋白：一项荟萃分析。
Rev Cardiovasc Med. 2019 Sep 30;20(3):161-169. doi: 10.31083/j.rcm.2019.03.524.
7
Peripheral Artery Disease and Transcatheter Aortic Valve Replacement Outcomes: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Therapy Registry.外周动脉疾病与经导管主动脉瓣置换术结局：来自胸外科医师学会/美国心脏病学会经导管治疗登记处的报告。
Circ Cardiovasc Interv. 2017 Oct;10(10). doi: 10.1161/CIRCINTERVENTIONS.117.005456.
8
Atrial Fibrillation Is Associated With Increased Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the Placement of Aortic Transcatheter Valve (PARTNER) Trial.心房颤动与经导管主动脉瓣置换术患者死亡率增加相关：来自主动脉经导管瓣膜置入（PARTNER）试验的见解。
Circ Cardiovasc Interv. 2016 Jan;9(1):e002766. doi: 10.1161/CIRCINTERVENTIONS.115.002766.
9
Implications of Concomitant Tricuspid Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement for Degenerated Surgical Aortic Bioprosthesis: Insights From the PARTNER 2 Aortic Valve-in-Valve Registry.行经导管主动脉瓣置换术治疗退行性外科生物瓣患者并发三尖瓣反流的意义：来自 PARTNER 2 主动脉瓣瓣中瓣注册研究的结果。
JACC Cardiovasc Interv. 2018 Jun 25;11(12):1154-1160. doi: 10.1016/j.jcin.2018.03.019.
10
Degenerative mitral regurgitation predicts worse outcomes in patients undergoing transcatheter aortic valve replacement.退行性二尖瓣反流会增加行经导管主动脉瓣置换术患者的不良预后。
Catheter Cardiovasc Interv. 2018 Sep 1;92(3):574-582. doi: 10.1002/ccd.27607. Epub 2018 Mar 30.

引用本文的文献

1
Clinical Outcomes and Prognostic Implications of TAVR in Patients With Active Cancer: A Meta-Analysis.经导管主动脉瓣置换术（TAVR）治疗活动性癌症患者的临床结局及预后意义：一项荟萃分析
Clin Cardiol. 2025 Mar;48(3):e70121. doi: 10.1002/clc.70121.
2
Outcomes and Adverse Effects of Transcatheter Aortic Valve Replacement (TAVR) in Cancer Patients: A Meta-Analysis.癌症患者经导管主动脉瓣置换术（TAVR）的疗效及不良反应：一项荟萃分析
Cureus. 2024 Nov 11;16(11):e73442. doi: 10.7759/cureus.73442. eCollection 2024 Nov.
3
Outcomes of patients with active cancer after transcatheter aortic valve replacement: an updated meta-analysis.经导管主动脉瓣置换术后活动性癌症患者的结局：一项更新的荟萃分析。
Cardiooncology. 2024 Sep 2;10(1):55. doi: 10.1186/s40959-024-00256-8.
4
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document.经导管主动脉瓣植入术患者的高出血风险定义：VARC-HBR 共识文件。
EuroIntervention. 2024 May 10;20(9):536-550. doi: 10.4244/EIJ-D-23-01020.
5
Midterm outcomes of transcatheter aortic valve replacement in patients with active cancer.经导管主动脉瓣置换术治疗活动性癌症患者的中期结果。
Open Heart. 2024 Feb 27;11(1):e002573. doi: 10.1136/openhrt-2023-002573.
6
Transcatheter Aortic Valve Replacement in Patients With or Without Active Cancer.经导管主动脉瓣置换术治疗伴或不伴活动性癌症的患者。
J Am Heart Assoc. 2023 Nov 7;12(21):e030072. doi: 10.1161/JAHA.123.030072. Epub 2023 Oct 27.
7
Association Between Previous or Active Cancer and Clinical Outcomes in TAVR Patients: A Systematic Review and Meta-Analysis of 255,840 Patients.经导管主动脉瓣置换术（TAVR）患者既往或活动性癌症与临床结局之间的关联：对255,840例患者的系统评价和荟萃分析
Front Cardiovasc Med. 2021 Nov 2;8:763557. doi: 10.3389/fcvm.2021.763557. eCollection 2021.

本文引用的文献

1
Transcatheter Aortic Valve Replacement in Oncology Patients With Severe Aortic Stenosis.经导管主动脉瓣置换术治疗严重主动脉瓣狭窄的肿瘤患者。
JACC Cardiovasc Interv. 2019 Jan 14;12(1):78-86. doi: 10.1016/j.jcin.2018.10.026.
2
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017年美国心脏协会/美国心脏病学会对2014年《美国心脏协会/美国心脏病学会瓣膜性心脏病患者管理指南》的重点更新：美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2017 Jul 11;70(2):252-289. doi: 10.1016/j.jacc.2017.03.011. Epub 2017 Mar 15.
3
Two-year survival of patients screened for transcatheter aortic valve replacement with potentially malignant incidental findings in initial body computed tomography.在初次胸部计算机断层扫描中发现潜在恶性偶然病变的经导管主动脉瓣置换术筛查患者的两年生存率
Eur Heart J Cardiovasc Imaging. 2015 Jul;16(7):731-7. doi: 10.1093/ehjci/jev055. Epub 2015 Mar 10.
4
Management and outcomes of severe aortic stenosis in cancer patients.癌症患者严重主动脉瓣狭窄的管理和结局。
Am Heart J. 2011 Jun;161(6):1125-32. doi: 10.1016/j.ahj.2011.03.013. Epub 2011 May 11.